Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-02-05 @ 5:39 PM
Study NCT ID:
NCT00048633
Status:
COMPLETED
Last Update Posted:
2012-05-23
First Post:
2002-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study to Evaluate Tariquidar (XR9576), a Selective MDR-1 Inhibitor, in Chemotherapy Resistant Advanced Breast Cancer
Sponsor:
QLT Inc.
Organization: